These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36805918)

  • 1. HER2 as a potential therapeutic target on quiescent prostate cancer cells.
    Yumoto K; Rashid J; Ibrahim KG; Zielske SP; Wang Y; Omi M; Decker AM; Jung Y; Sun D; Remmer HA; Mishina Y; Buttitta LA; Taichman RS; Cackowski FC
    Transl Oncol; 2023 May; 31():101642. PubMed ID: 36805918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tamoxifen overcomes the trastuzumab-resistance of SK-BR-3 tumorspheres by targeting crosstalk between cytoplasmic estrogen receptor α and the EGFR/HER2 signaling pathway.
    Kwon YS; Nam KS; Kim S
    Biochem Pharmacol; 2021 Aug; 190():114635. PubMed ID: 34058187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SNHG1 opposes quiescence and promotes docetaxel sensitivity in prostate cancer.
    Zielske SP; Chen W; Ibrahim KG; Cackowski FC
    BMC Cancer; 2023 Jul; 23(1):672. PubMed ID: 37464317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mer Tyrosine Kinase Regulates Disseminated Prostate Cancer Cellular Dormancy.
    Cackowski FC; Eber MR; Rhee J; Decker AM; Yumoto K; Berry JE; Lee E; Shiozawa Y; Jung Y; Aguirre-Ghiso JA; Taichman RS
    J Cell Biochem; 2017 Apr; 118(4):891-902. PubMed ID: 27753136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safrana l Prevents Prostate Cancer Recurrence by Blocking the Re-activation of Quiescent Cancer Cells
    Jiang X; Li Y; Feng JL; Nik Nabil WN; Wu R; Lu Y; Liu H; Xi ZC; Xu HX
    Front Cell Dev Biol; 2020; 8():598620. PubMed ID: 33392189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor removal limits prostate cancer cell dissemination in bone and osteoblasts induce cancer cell dormancy through focal adhesion kinase.
    Liu R; Su S; Xing J; Liu K; Zhao Y; Stangis M; Jacho DP; Yildirim-Ayan ED; Gatto-Weis CM; Chen B; Li X
    J Exp Clin Cancer Res; 2023 Oct; 42(1):264. PubMed ID: 37821954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visualization of endogenous p27 and Ki67 reveals the importance of a c-Myc-driven metabolic switch in promoting survival of quiescent cancer cells.
    La T; Chen S; Guo T; Zhao XH; Teng L; Li D; Carnell M; Zhang YY; Feng YC; Cole N; Brown AC; Zhang D; Dong Q; Wang JY; Cao H; Liu T; Thorne RF; Shao FM; Zhang XD; Jin L
    Theranostics; 2021; 11(19):9605-9622. PubMed ID: 34646389
    [No Abstract]   [Full Text] [Related]  

  • 9. Cellular dormancy in minimal residual disease following targeted therapy.
    Ruth JR; Pant DK; Pan TC; Seidel HE; Baksh SC; Keister BA; Singh R; Sterner CJ; Bakewell SJ; Moody SE; Belka GK; Chodosh LA
    Breast Cancer Res; 2021 Jun; 23(1):63. PubMed ID: 34088357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abscisic acid regulates dormancy of prostate cancer disseminated tumor cells in the bone marrow.
    Jung Y; Cackowski FC; Yumoto K; Decker AM; Wang Y; Hotchkin M; Lee E; Buttitta L; Taichman RS
    Neoplasia; 2021 Jan; 23(1):102-111. PubMed ID: 33296752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel cell-cycle-indicator, mVenus-p27K-, identifies quiescent cells and visualizes G0-G1 transition.
    Oki T; Nishimura K; Kitaura J; Togami K; Maehara A; Izawa K; Sakaue-Sawano A; Niida A; Miyano S; Aburatani H; Kiyonari H; Miyawaki A; Kitamura T
    Sci Rep; 2014 Feb; 4():4012. PubMed ID: 24500246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A genetically engineered oncolytic adenovirus decoys and lethally traps quiescent cancer stem-like cells in S/G2/M phases.
    Yano S; Tazawa H; Hashimoto Y; Shirakawa Y; Kuroda S; Nishizaki M; Kishimoto H; Uno F; Nagasaka T; Urata Y; Kagawa S; Hoffman RM; Fujiwara T
    Clin Cancer Res; 2013 Dec; 19(23):6495-505. PubMed ID: 24081978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor Dormancy and Slow-Cycling Cancer Cells.
    Davis JE; Kirk J; Ji Y; Tang DG
    Adv Exp Med Biol; 2019; 1164():199-206. PubMed ID: 31576550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth Arrest-Specific 6 (GAS6) Promotes Prostate Cancer Survival by G
    Lee E; Decker AM; Cackowski FC; Kana LA; Yumoto K; Jung Y; Wang J; Buttitta L; Morgan TM; Taichman RS
    J Cell Biochem; 2016 Dec; 117(12):2815-2824. PubMed ID: 27153245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Esophageal Adenocarcinoma Cells and Xenograft Tumors Exposed to Erb-b2 Receptor Tyrosine Kinase 2 and 3 Inhibitors Activate Transforming Growth Factor Beta Signaling, Which Induces Epithelial to Mesenchymal Transition.
    Ebbing EA; Steins A; Fessler E; Stathi P; Lesterhuis WJ; Krishnadath KK; Vermeulen L; Medema JP; Bijlsma MF; van Laarhoven HWM
    Gastroenterology; 2017 Jul; 153(1):63-76.e14. PubMed ID: 28286209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring Spontaneous Quiescence and Asynchronous Proliferation-Quiescence Decisions in Prostate Cancer Cells.
    Pulianmackal AJ; Sun D; Yumoto K; Li Z; Chen YC; Patel MV; Wang Y; Yoon E; Pearson A; Yang Q; Taichman R; Cackowski FC; Buttitta LA
    Front Cell Dev Biol; 2021; 9():728663. PubMed ID: 34957090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined targeting of EGFR and HER2 against prostate cancer stem cells.
    Rossini A; Giussani M; Ripamonti F; Aiello P; Regondi V; Balsari A; Triulzi T; Tagliabue E
    Cancer Biol Ther; 2020 May; 21(5):463-475. PubMed ID: 32089070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro modeling of HER2-targeting therapy in disseminated prostate cancer.
    Andersson J; Rosestedt M; Asplund V; Yavari N; Orlova A
    Int J Oncol; 2014 Nov; 45(5):2153-8. PubMed ID: 25176024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection and isolation of disseminated tumor cells in bone marrow of patients with clinically localized prostate cancer.
    Cackowski FC; Wang Y; Decker JT; Sifuentes C; Weindorf S; Jung Y; Wang Y; Decker AM; Yumoto K; Szerlip N; Buttitta L; Pienta KJ; Morgan TM; Taichman RS
    Prostate; 2019 Oct; 79(14):1715-1727. PubMed ID: 31449673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate cancer dormancy and recurrence.
    Cackowski FC; Heath EI
    Cancer Lett; 2022 Jan; 524():103-108. PubMed ID: 34624433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.